About the Authors

Daniel Rüdiger

Contributed equally to this work with: Daniel Rüdiger, Lars Pelz

Roles Conceptualization, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing

ruedigerd@mpi-magdeburg.mpg.de (DR); kupke@mpi-magdeburg.mpg.de (SYK)

Affiliation Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany

Lars Pelz

Contributed equally to this work with: Daniel Rüdiger, Lars Pelz

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

Affiliation Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany

Marc D. Hein

Roles Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing

Affiliation Chair of Bioprocess Engineering, Institute of Process Engineering, Faculty of Process & Systems Engineering, Otto-von-Guericke University, Magdeburg, Germany

Sascha Y. Kupke

Roles Conceptualization, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing

ruedigerd@mpi-magdeburg.mpg.de (DR); kupke@mpi-magdeburg.mpg.de (SYK)

Affiliation Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany

Udo Reichl

Roles Conceptualization, Funding acquisition, Project administration, Supervision, Writing – review & editing

Affiliations Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany, Chair of Bioprocess Engineering, Institute of Process Engineering, Faculty of Process & Systems Engineering, Otto-von-Guericke University, Magdeburg, Germany

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: A patent for the use of OP7 (a DIP containing point mutations instead of a deletion in viral genome segment 7) as an antiviral agent for treatment of IAV infection is pending. Patent holders are S.Y.K. and U.R. Another patent for the use of DI244 and OP7 as an antiviral agent for treatment of coronavirus infection is pending. Patent holders are S.Y.K., U.R. and M.D.H. The remaining authors declare no conflict of interest.